rs17793014
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001366028.2(DNAH12):c.5253+263A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 1,340,342 control chromosomes in the GnomAD database, including 113,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.32 ( 8899 hom., cov: 33)
Exomes 𝑓: 0.41 ( 104539 hom. )
Consequence
DNAH12
NM_001366028.2 intron
NM_001366028.2 intron
Scores
17
Clinical Significance
Conservation
PhyloP100: -0.272
Genes affected
DNAH12 (HGNC:2943): (dynein axonemal heavy chain 12) Predicted to enable several functions, including ATP binding activity; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in cilium; cytoplasm; and microtubule. Predicted to be part of dynein complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=9.2354417E-4).
BP6
Variant 3-57428370-T-A is Benign according to our data. Variant chr3-57428370-T-A is described in ClinVar as [Benign]. Clinvar id is 402634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.5253+263A>T | intron_variant | ENST00000495027.6 | NP_001352957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.5253+263A>T | intron_variant | 5 | NM_001366028.2 | ENSP00000418137 | P1 | |||
DNAH12 | ENST00000351747.6 | c.5262A>T | p.Lys1754Asn | missense_variant | 35/59 | 5 | ENSP00000295937 |
Frequencies
GnomAD3 genomes AF: 0.320 AC: 48640AN: 152000Hom.: 8906 Cov.: 33
GnomAD3 genomes
AF:
AC:
48640
AN:
152000
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.339 AC: 49201AN: 144964Hom.: 9501 AF XY: 0.347 AC XY: 26637AN XY: 76752
GnomAD3 exomes
AF:
AC:
49201
AN:
144964
Hom.:
AF XY:
AC XY:
26637
AN XY:
76752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.412 AC: 489367AN: 1188224Hom.: 104539 Cov.: 20 AF XY: 0.411 AC XY: 241572AN XY: 587254
GnomAD4 exome
AF:
AC:
489367
AN:
1188224
Hom.:
Cov.:
20
AF XY:
AC XY:
241572
AN XY:
587254
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.320 AC: 48657AN: 152118Hom.: 8899 Cov.: 33 AF XY: 0.316 AC XY: 23516AN XY: 74352
GnomAD4 genome
AF:
AC:
48657
AN:
152118
Hom.:
Cov.:
33
AF XY:
AC XY:
23516
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1618
ALSPAC
AF:
AC:
1645
ExAC
AF:
AC:
7163
Asia WGS
AF:
AC:
728
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
P
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Polyphen
B
Vest4
MutPred
Loss of ubiquitination at K1754 (P = 0.0192);
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at